Compass Therapeutics, Inc. (CMPX)
0.6882
+0.01
(+1.43%)
USD |
NASDAQ |
Nov 20, 16:00
0.6834
0.00 (0.00%)
After-Hours: 20:00
Compass Therapeutics Shareholders Equity (Quarterly) : 142.57M for Sept. 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 142.57M |
| June 30, 2026 | 166.05M |
| March 31, 2026 | 186.47M |
| December 31, 2025 | 196.79M |
| September 30, 2025 | 209.61M |
| June 30, 2025 | 93.21M |
| March 31, 2025 | 110.28M |
| December 31, 2024 | 125.23M |
| September 30, 2024 | 138.40M |
| June 30, 2024 | 146.10M |
| March 31, 2024 | 157.06M |
| December 31, 2023 | 148.54M |
| September 30, 2023 | 160.04M |
| June 30, 2023 | 168.29M |
| Date | Value |
|---|---|
| March 31, 2023 | 175.26M |
| December 31, 2022 | 181.64M |
| September 30, 2022 | 116.12M |
| June 30, 2022 | 126.93M |
| March 31, 2022 | 134.49M |
| December 31, 2021 | 140.08M |
| September 30, 2021 | 23.89M |
| June 30, 2021 | 28.88M |
| March 31, 2021 | 33.47M |
| December 31, 2020 | 39.94M |
| September 30, 2020 | 47.29M |
| June 30, 2020 | 53.25M |
| March 31, 2020 | -124.76M |
| December 31, 2019 | -118.60M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | 588.60M |
| Capricor Therapeutics, Inc. | 209.76M |
| Ardelyx, Inc. | 164.05M |
| Biomea Fusion, Inc. | 7.586M |
| ARS Pharmaceuticals, Inc. | -11.96M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 174.50M |
| Total Liabilities (Quarterly) | 31.93M |
| Debt to Equity Ratio | 0.0648 |
| Current Ratio | 6.792 |
| Net Debt Paydown Yield | 0.07% |